Patents by Inventor Jaesook Park

Jaesook Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10393744
    Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: August 27, 2019
    Assignee: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung Choi, Seong-Yun Jeong, Si Yeol Song, Kyoung Jin Lee, Jinhyang Choi, Jaesook Park, Seok Soon Park, Jae Hee Lee
  • Publication number: 20170328906
    Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 16, 2017
    Applicant: UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Eun Kyung CHOI, Seong-Yun JEONG, Si Yeol SONG, Kyoung Jin LEE, Jinhyang CHOI, Jaesook PARK, Seok Soon PARK, Jae Hee LEE
  • Patent number: 9142200
    Abstract: There is provided a wind synthesizer controller playable by the same manipulation as that of a customary musical instrument as well as able to obtain accurate scale information and volume information. The wind synthesizer controller includes a microphone, an expiration intensity measuring unit, and a controller. The microphone detects a sound generated by flowed in expiration. The expiration intensity measuring unit measures intensity of the expiration on the basis of a detected sound signal. The controller generates volume information on the basis of the measured expiration intensity. The volume information at least includes note on, note off, and velocity.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: September 22, 2015
    Assignee: Jaesook Park
    Inventor: Jaesook Park
  • Publication number: 20150101477
    Abstract: There is provided a wind synthesizer controller playable by the same manipulation as that of a customary musical instrument as well as able to obtain accurate scale information and volume information. The wind synthesizer controller includes a microphone, an expiration intensity measuring unit, and a controller. The microphone detects a sound generated by flowed in expiration. The expiration intensity measuring unit measures intensity of the expiration on the basis of a detected sound signal. The controller generates volume information on the basis of the measured expiration intensity. The volume information at least includes note on, note off, and velocity.
    Type: Application
    Filed: September 16, 2014
    Publication date: April 16, 2015
    Inventor: Jaesook PARK
  • Publication number: 20110059023
    Abstract: Devices and methods are provided for image identification of contrast agents comprising nanopartiles. The imaging devices and methods may also be configured to identify target tissues from surrounding tissues such as disease conditions (e.g. cancer tumors) through narrow-band imaging of tissue. Contrast agents such as near-infrared absorbing nanoparticles may be introduced to an organism to distinguish target cells, tissues, or structures from normal tissue. The contrast agent is allowed to preferentially accumulate in the target cells, tissues or structures. As the contrast agents are adapted to preferentially absorb one or more wavelengths of light, the reflection of one wavelength or band of wavelengths by the contrast agents is compared to a separate wavelength or band of wavelengths to identify the target cells, tissues, or structures. In this way, the comparisons identify the presence of the preferential accumulation of the contrast agent in the target cells, tissues or structures.
    Type: Application
    Filed: March 19, 2009
    Publication date: March 10, 2011
    Inventors: James W. Tunnell, Jon A. Schwartz, Jaesook Park, Priyaveena Puvanakrishnan, J. Donald Payne